The SAPIEN transcatheter heart valve is a feasible option for high-risk patients with severe aortic stenosis, but valve leakage remains a significant issue. At five years, death and stroke rates were equivalent to open-heart surgery, but rehospitalization rates and functional outcomes differed.
A rare Caribbean coral species has been successfully bred and raised in the lab, providing a rare glimpse into its procreation process. The research could aid future conservation efforts by increasing genetic diversity and helping populations adapt to climate change.
The SAPIEN 3 heart valve demonstrated lower death, stroke, and paravalvular leak rates than earlier generation devices in high-risk patients. In intermediate-risk patients, the device showed encouraging results, with a reduced rate of major vascular complications and fewer instances of heart attacks and annular rupture.
A new brain shield device has shown improved in-hospital safety outcomes, including lower rates of major adverse cardiovascular and cerebrovascular events. The device also demonstrated benefits for patients' cognitive scores at discharge, with better performance on neurocognitive tests.
Research shows that CT scans paired with standard care lead to more accurate diagnoses of coronary artery disease, altering follow-up testing and treatments. This results in a lower incidence of heart attacks among patients receiving the test compared to those receiving usual care.
Researchers found that bat activity was lower in street-lit areas than dark locations with similar habitat. Only Leisler's bat showed a positive association with street lighting, highlighting the need to reconsider urban planning strategies.
Researchers found that TAVR improves survival rates and quality of life for elderly patients with severe aortic stenosis. The study compared five-year outcomes of TAVR with standard therapy, showing significant benefits in the TAVR group.
The study found that Bendavia did not prevent irreversible injury to the heart but showed a trend towards improved heart pumping function. The drug is well-tolerated but lacks significant benefits in reducing scarring from angioplasty after a heart attack.
A new device called TriGuard has been tested in a multicenter trial to protect the brain during heart-valve replacement procedures. The results show that patients with protection had fewer ischemic brain lesions and improvements in cognitive function, including short-term memory and delayed memory.
A recent survey of 236 cardiologists found significant gaps in their knowledge about heart-healthy diets, with only 13.5% feeling adequately trained to discuss nutrition with patients. Dark chocolate was also shown to have health benefits in sedentary older adults, improving energy levels and exercise stamina.
Research by Queensland University of Technology highlights the difficulties faced by police during death investigations, including emotional re-traumatization of bereaved families. Junior officers are often tasked with gathering evidence while comforting family members, leading to concerns about their preparation and cultural competence.
A study published in JAMA Network found that combining folic acid with the hypertension medication enalapril significantly reduced the risk of first stroke among over 20,000 Chinese adults with high blood pressure. The treatment also showed significant reductions in ischemic stroke and composite cardiovascular events.
Self-expanding TAVR shows continued survival advantage over standard surgery in high-risk patients with severe aortic stenosis. At two years, TAVR had 4.8% more survivors than surgery, and lower rates of strokes and major cardiovascular events.
A novel anti-clotting therapy was compared to established anticoagulants in a Phase III trial, but showed similar efficacy and higher moderate to severe bleeding rates, leading to its early termination due to allergic reactions.
Patients taking evolocumab, a new class of cholesterol-lowering medications, were half as likely to die or experience a heart attack/stroke compared to those on standard care. The study found that patients treated with evolocumab had significantly lower rates of cardiovascular events and adverse effects.
The study found that transcatheter mitral valve repair was successful for 91.8% of patients and reduced mitral regurgitation to mild or less in 63.7%. Institutional experience had a bearing on procedural success but not major adverse outcomes.
A study by University of Exeter researchers found that artificial light at night inhibits flowering in certain plants and suppresses aphid populations. The low-intensity amber light was more detrimental to the pea aphid population than white light, highlighting complex interactions between predators and resources.